Correlation Between Elamex SA and MusclePharm
Can any of the company-specific risk be diversified away by investing in both Elamex SA and MusclePharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elamex SA and MusclePharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elamex SA de and MusclePharm, you can compare the effects of market volatilities on Elamex SA and MusclePharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elamex SA with a short position of MusclePharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elamex SA and MusclePharm.
Diversification Opportunities for Elamex SA and MusclePharm
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Elamex and MusclePharm is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Elamex SA de and MusclePharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MusclePharm and Elamex SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elamex SA de are associated (or correlated) with MusclePharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MusclePharm has no effect on the direction of Elamex SA i.e., Elamex SA and MusclePharm go up and down completely randomly.
Pair Corralation between Elamex SA and MusclePharm
Assuming the 90 days horizon Elamex SA is expected to generate 246.35 times less return on investment than MusclePharm. But when comparing it to its historical volatility, Elamex SA de is 252.45 times less risky than MusclePharm. It trades about 0.07 of its potential returns per unit of risk. MusclePharm is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 0.30 in MusclePharm on September 1, 2024 and sell it today you would lose (0.30) from holding MusclePharm or give up 100.0% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 85.48% |
Values | Daily Returns |
Elamex SA de vs. MusclePharm
Performance |
Timeline |
Elamex SA de |
MusclePharm |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Elamex SA and MusclePharm Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Elamex SA and MusclePharm
The main advantage of trading using opposite Elamex SA and MusclePharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elamex SA position performs unexpectedly, MusclePharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MusclePharm will offset losses from the drop in MusclePharm's long position.Elamex SA vs. Premier Foods Plc | Elamex SA vs. Torque Lifestyle Brands | Elamex SA vs. ConAgra Foods | Elamex SA vs. McCormick Company Incorporated |
MusclePharm vs. Chimerix | MusclePharm vs. Apogee Therapeutics, Common | MusclePharm vs. Canlan Ice Sports | MusclePharm vs. United Parks Resorts |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |